• Home
  • Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma.

Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma.

Author List
DeConti RC, Algazi AP, Andrews S, Urbas P, Born O, Stoeckigt D, Floren L, Hwang J, Weber J, Sondak VK, Daud AI
Publication
British journal of cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1479648
Publication Year
2010
PubMed ID
20924376
Publication Title
DeConti RC, Algazi AP, Andrews S, Urbas P, Born O, Stoeckigt D, Floren L, Hwang J, Weber J, Sondak VK, Daud AI. Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma. Br J Cancer. 2010 Nov 09; 103(10):1548-53.